1,2,3,4,6-pentakis-O-galloyl-beta-D-glucose has been researched along with mocetinostat in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
Czerwińska, M; Filipek, A; Kiss, AK; Naruszewicz, M | 1 |
2 other study(ies) available for 1,2,3,4,6-pentakis-O-galloyl-beta-D-glucose and mocetinostat
Article | Year |
---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Oenothera paradoxa defatted seeds extract and its bioactive component penta-O-galloyl-β-D-glucose decreased production of reactive oxygen species and inhibited release of leukotriene B4, interleukin-8, elastase, and myeloperoxidase in human neutrophils.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Cells, Cultured; Humans; Hydrolyzable Tannins; Interleukin-8; Leukotriene B4; Neutrophils; Oenothera; Pancreatic Elastase; Peroxidase; Plant Extracts; Reactive Oxygen Species; Seeds; Young Adult | 2010 |